| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |